Laura Else

2.5k total citations
84 papers, 1.6k citations indexed

About

Laura Else is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Laura Else has authored 84 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Infectious Diseases, 38 papers in Virology and 21 papers in Epidemiology. Recurrent topics in Laura Else's work include HIV/AIDS drug development and treatment (59 papers), HIV Research and Treatment (38 papers) and HIV/AIDS Research and Interventions (35 papers). Laura Else is often cited by papers focused on HIV/AIDS drug development and treatment (59 papers), HIV Research and Treatment (38 papers) and HIV/AIDS Research and Interventions (35 papers). Laura Else collaborates with scholars based in United Kingdom, United States and Uganda. Laura Else's co-authors include David Back, Saye Khoo, Marta Boffito, Alieu Amara, Stephen Taylor, Victoria Watson, Sujan Dilly Penchala, Marco Siccardi, Akil Jackson and John Tjia and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Laura Else

82 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Else United Kingdom 25 1.2k 711 353 261 214 84 1.6k
Tim R. Cressey Thailand 24 1.3k 1.1× 627 0.9× 370 1.0× 348 1.3× 336 1.6× 123 1.7k
Agnes I. Veldkamp Netherlands 17 697 0.6× 510 0.7× 185 0.5× 140 0.5× 83 0.4× 27 943
Caroline Solas France 23 920 0.7× 430 0.6× 258 0.7× 162 0.6× 62 0.3× 94 1.5k
Laura Dickinson United Kingdom 19 662 0.5× 374 0.5× 163 0.5× 191 0.7× 84 0.4× 68 999
Paul A. Pham United States 17 1000 0.8× 507 0.7× 457 1.3× 135 0.5× 69 0.3× 38 1.5k
Concepta Merry Ireland 18 780 0.6× 411 0.6× 216 0.6× 187 0.7× 89 0.4× 29 1.1k
Brian L. Robbins United States 21 1.1k 0.9× 654 0.9× 397 1.1× 125 0.5× 53 0.2× 43 1.4k
Rolf P. G. van Heeswijk Netherlands 24 1.9k 1.5× 750 1.1× 846 2.4× 230 0.9× 71 0.3× 41 2.3k
F Mulcahy Ireland 19 800 0.6× 316 0.4× 594 1.7× 93 0.4× 118 0.6× 66 1.4k
Giorgio Gatti Italy 16 837 0.7× 316 0.4× 390 1.1× 110 0.4× 109 0.5× 38 1.2k

Countries citing papers authored by Laura Else

Since Specialization
Citations

This map shows the geographic impact of Laura Else's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Else with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Else more than expected).

Fields of papers citing papers by Laura Else

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Else. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Else. The network helps show where Laura Else may publish in the future.

Co-authorship network of co-authors of Laura Else

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Else. A scholar is included among the top collaborators of Laura Else based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Else. Laura Else is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Else, Laura, Sujan Dilly Penchala, Limakatso Lebina, et al.. (2022). Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue. Pharmaceutics. 14(6). 1285–1285. 1 indexed citations
3.
Petkov, Stefan, Carolina Herrera, Laura Else, et al.. (2022). Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in Africa. Frontiers in Immunology. 13. 1009978–1009978. 2 indexed citations
4.
Petkov, Stefan, Carolina Herrera, Laura Else, et al.. (2022). Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa. Frontiers in Immunology. 13. 965214–965214. 3 indexed citations
5.
Herrera, Carolina, Julianne Lwanga, Ming Lee, et al.. (2021). Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP). Journal of Antimicrobial Chemotherapy. 76(8). 2129–2136. 9 indexed citations
6.
Tiraboschi, Juan, Sujan Dilly Penchala, Laura Else, et al.. (2021). Total and Unbound Doravirine Concentrations and Viral Suppression in CSF. Clinical Infectious Diseases. 74(10). 1855–1858. 5 indexed citations
7.
Amara, Alieu, Sujan Dilly Penchala, Laura Else, et al.. (2021). The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva. Journal of Pharmaceutical and Biomedical Analysis. 206. 114356–114356. 61 indexed citations
8.
Cranston, Ross, Charlene S. Dezzutti, Nicola Richardson‐Harman, et al.. (2019). A Multiple Dose Phase 1 Assessment of Rilpivirine Long Acting in a Model of Preexposure Prophylaxis Against HIV. AIDS Research and Human Retroviruses. 35(9). 794–804. 8 indexed citations
9.
Jackson, Akil, Laura Else, Christopher Higgs, et al.. (2017). Pharmacokinetics and pharmacodynamics of the nucleoside sparing dual regimen containing rilpivirine plus darunavir/ritonavir in treatment-naïve HIV-1-infected individuals. HIV Clinical Trials. 19(1). 31–37. 4 indexed citations
10.
Waitt, Catriona, Adeniyi Olagunju, Alieu Amara, et al.. (2017). Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC–MS/MS. Journal of Chromatography B. 1060. 300–307. 27 indexed citations
11.
Nightingale, Sam, Anna María Geretti, Apostolos Beloukas, et al.. (2016). Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia. Journal of NeuroVirology. 22(6). 852–860. 41 indexed citations
12.
Penchala, Sujan Dilly, Laura Else, Deirdre Egan, et al.. (2016). The development and application of a novel LC–MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma. Journal of Chromatography B. 1027. 174–180. 29 indexed citations
13.
Coll, J, José Moltó, Jaume Boix, et al.. (2015). Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers. AIDS. 29(16). 2149–2154. 14 indexed citations
14.
Mora‐Peris, Borja, Alan Winston, Lucy Garvey, et al.. (2015). HIV-1 CNSin vitroinfectivity models based on clinical CSF samples. Journal of Antimicrobial Chemotherapy. 71(1). 235–243. 5 indexed citations
15.
Penrose, Kerri J., Urvi M. Parikh, Constantinos G. Panousis, et al.. (2014). Selection of Rilpivirine Resistant HIV-1 in a Seroconverter on Long-acting Rilpivirine (TMC278LA) from the Lowest Dose Arm of the SSAT 040 Trial. AIDS Research and Human Retroviruses. 30(S1). A69–A69. 5 indexed citations
16.
Jackson, Akil, Antonio D’Avolio, Graeme Moyle, et al.. (2014). Pharmacokinetics of the co-administration of boceprevir and St John's wort to male and female healthy volunteers. Journal of Antimicrobial Chemotherapy. 69(7). 1911–1915. 14 indexed citations
17.
Penchala, Sujan Dilly, et al.. (2013). Validation of an electrospray ionisation LC–MS/MS method for quantitative analysis of telaprevir and its R-diastereomer. Journal of Chromatography B. 932. 100–110. 7 indexed citations
18.
Else, Laura, Akil Jackson, Rebekah Puls, et al.. (2011). Pharmacokinetics of Lamivudine and Lamivudine-Triphosphate after Administration of 300 Milligrams and 150 Milligrams Once Daily to Healthy Volunteers: Results of the ENCORE 2 Study. Antimicrobial Agents and Chemotherapy. 56(3). 1427–1433. 28 indexed citations
19.
Dickinson, Laura, Marta Boffito, D.J. Back, et al.. (2009). Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers. Journal of Antimicrobial Chemotherapy. 63(6). 1233–1243. 28 indexed citations
20.
Yilmaz, Aylin, Victoria Watson, Laura Else, & Magnus Gisslén. (2009). Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients. AIDS. 23(18). 2537–2540. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim R. Cressey Breakdown of academic impact, for papers by Agnes I. Veldkamp Breakdown of academic impact, for papers by Caroline Solas Breakdown of academic impact, for papers by Laura Dickinson Breakdown of academic impact, for papers by Paul A. Pham Breakdown of academic impact, for papers by Concepta Merry Breakdown of academic impact, for papers by Brian L. Robbins Breakdown of academic impact, for papers by Rolf P. G. van Heeswijk Breakdown of academic impact, for papers by F Mulcahy Breakdown of academic impact, for papers by Giorgio Gatti
Rankless by CCL
2026